Greenwich LifeSciences (GLSI) Provides Update on Phase III Trial

Go back to Greenwich LifeSciences (GLSI) Provides Update on Phase III Trial
(NASDAQ: GLSI) Delayed: 17.34 --0 (-0%)
Previous Close $17.34    52 Week High
Open $17.34    52 Week Low
Day High $17.34    P/E N/A 
Day Low $17.34    EPS
Volume 3,439